Grant T Baldwin
Overview
Explore the profile of Grant T Baldwin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
2361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schauer G, Dilley J, Roehler D, Sheehy T, Filley J, Broschart S, et al.
Int J Drug Policy
. 2021 Aug;
98:103384.
PMID: 34364201
Background And Aims: Following emergency declarations related to COVID-19 in the United States, many states issued stay-at-home orders and designated essential business categories. Most states allowed medical and/or non-medical adult-use...
12.
Baldwin G, Seth P, Noonan R
JAMA
. 2021 Feb;
325(12):1151-1152.
PMID: 33571368
No abstract available.
13.
King B, Jones C, Baldwin G, Briss P
Nicotine Tob Res
. 2020 Dec;
22(Suppl 1):S96-S99.
PMID: 33320257
Implications In this commentary, we describe the evidence-based approach used to identify the primary cause of EVALI and to curb the 2019 outbreak. We also discuss future research opportunities and...
14.
Reagan-Steiner S, Gary J, Matkovic E, Ritter J, Shieh W, Martines R, et al.
Lancet Respir Med
. 2020 Aug;
8(12):1219-1232.
PMID: 32763198
Background: Since August, 2019, US public health officials have been investigating a national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI). A spectrum of histological patterns consistent with...
15.
Werner A, Koumans E, Chatham-Stephens K, Salvatore P, Armatas C, Byers P, et al.
N Engl J Med
. 2020 Apr;
382(17):1589-1598.
PMID: 32320569
Background: As of January 7, 2020, a total of 2558 hospitalized patients with nonfatal cases and 60 patients with fatal cases of e-cigarette, or vaping, product use-associated lung injury (EVALI)...
16.
Blount B, Karwowski M, Morel-Espinosa M, Rees J, Sosnoff C, Cowan E, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Jan;
69(4):116.
PMID: 31999686
No abstract available.
17.
King B, Jones C, Baldwin G, Briss P
N Engl J Med
. 2020 Jan;
382(8):689-691.
PMID: 31951683
No abstract available.
18.
Blount B, Karwowski M, Shields P, Morel-Espinosa M, Valentin-Blasini L, Gardner M, et al.
N Engl J Med
. 2019 Dec;
382(8):697-705.
PMID: 31860793
Background: The causative agents for the current national outbreak of electronic-cigarette, or vaping, product use-associated lung injury (EVALI) have not been established. Detection of toxicants in bronchoalveolar-lavage (BAL) fluid from...
19.
Jatlaoui T, Wiltz J, Kabbani S, Siegel D, Koppaka R, Montandon M, et al.
MMWR Morb Mortal Wkly Rep
. 2019 Nov;
68(46):1081-1086.
PMID: 31751322
CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders are investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung...
20.
Blount B, Karwowski M, Morel-Espinosa M, Rees J, Sosnoff C, Cowan E, et al.
MMWR Morb Mortal Wkly Rep
. 2019 Nov;
68(45):1040-1041.
PMID: 31725707
CDC, the Food and Drug Administration (FDA), state and local health departments, and multiple public health and clinical partners are investigating a national outbreak of e-cigarette, or vaping, product use-associated...